During the past decade, Jackson Heart Study conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jackson Heart Study" #1 collaborator was "Boston University" with 1 trials as a collaborator, "Broad Institute" with 1 trials as a collaborator, "Framingham Heart Study" with 1 trials as a collaborator, "Jackson Heart Study" with 1 trials as a collaborator and "Partners HealthCare" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Jackson Heart Study" are "Cardiovascular Diseases" (1 trials), "Coronary Disease" (1 trials), "Genetic Predisposition to Disease" (1 trials) and "Seemingly Healthy" (1 trials). Many other conditions were trialed in "Jackson Heart Study" in a lesser frequency.

Most popular intervention types in "Jackson Heart Study" are "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Genomic Sequencing" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jackson Heart Study" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Jackson Heart Study". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Jackson Heart Study, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jackson Heart Study, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".